Suzanne Lentzsch

22PUBLICATIONS
95CO-AUTHORS
Gene and molecular therapyAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 10, 2026
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.

|Jul 29, 2026
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis.

|May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

|Apr 08, 2026
A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma.

Hans C Lee, Wouter J Plattel, Simon J Harrison

|Nov 07, 2025
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

Samer Al Hadidi, Aniko Szabo, Bhavesh Mohan Lal

|Dec 02, 2024
The Undetermined Significance of Screening for Monoclonal Gammopathy of Undetermined Significance.

Lindor Qunaj, Suzanne Lentzsch, Alfred I Neugut

Pageof 4

Frequent Collaborators

4 joint publications

Vaishali Sanchorawala

3 joint publications

Jing Fu

2 joint publications

Mathew S Maurer

2 joint publications

Sundar Jagannath